199 related articles for article (PubMed ID: 37291599)
1. Moderators of the cost-effectiveness of transdiagnostic CBT for anxiety disorders over an 8-month time horizon using a net-benefit regression framework.
Chapdelaine A; Vasiliadis HM; Provencher MD; Norton PJ; Roberge P
BMC Health Serv Res; 2023 Jun; 23(1):596. PubMed ID: 37291599
[TBL] [Abstract][Full Text] [Related]
2. Cost-Effectiveness of Group Transdiagnostic Cognitive Behavioural Therapy for Anxiety Disorders in Primary Care Settings: Economic Evaluation From the Healthcare System Perspective Over a 1-Year Time Horizon.
Vasiliadis HM; Lamoureux-Lamarche C; Chapdelaine A; Provencher MD; Norton PJ; Berbiche D; Roberge P
Can J Psychiatry; 2024 Jan; 69(1):43-53. PubMed ID: 37461378
[TBL] [Abstract][Full Text] [Related]
3. A pragmatic randomized controlled trial of group transdiagnostic cognitive-behaviour therapy for anxiety disorders in primary care: study protocol.
Roberge P; Provencher MD; Gosselin P; Vasiliadis HM; Gaboury I; Benoit A; Antony MM; Chaillet N; Houle J; Hudon C; Norton PJ
BMC Psychiatry; 2018 Oct; 18(1):320. PubMed ID: 30285672
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of transdiagnostic group cognitive behavioural therapy for anxiety disorders
Chapdelaine A; Vasiliadis HM; Provencher MD; Norton PJ; Roberge P
Psychol Med; 2023 Jan; ():1-13. PubMed ID: 36695038
[TBL] [Abstract][Full Text] [Related]
5. Therapist telephone-delivered CBT and web-based CBT compared with treatment as usual in refractory irritable bowel syndrome: the ACTIB three-arm RCT.
Everitt H; Landau S; Little P; Bishop FL; O'Reilly G; Sibelli A; Holland R; Hughes S; Windgassen S; McCrone P; Goldsmith K; Coleman N; Logan R; Chalder T; Moss-Morris R
Health Technol Assess; 2019 Apr; 23(17):1-154. PubMed ID: 31042143
[TBL] [Abstract][Full Text] [Related]
6. Group transdiagnostic cognitive-behavior therapy for anxiety disorders: a pragmatic randomized clinical trial.
Roberge P; Provencher MD; Gaboury I; Gosselin P; Vasiliadis HM; Benoît A; Carrier N; Antony MM; Chaillet N; Houle J; Hudon C; Norton PJ
Psychol Med; 2020 Dec; 52(13):1-11. PubMed ID: 33261700
[TBL] [Abstract][Full Text] [Related]
7. The effectiveness of transdiagnostic cognitive behavioural therapy for anxiety disorders: the role of and impact of comorbid depression.
George MG; Roberge P; Provencher MD; Norton PJ
Cogn Behav Ther; 2024 Jan; 53(1):105-118. PubMed ID: 37934006
[TBL] [Abstract][Full Text] [Related]
8. Computerised cognitive behaviour therapy for depression and anxiety update: a systematic review and economic evaluation.
Kaltenthaler E; Brazier J; De Nigris E; Tumur I; Ferriter M; Beverley C; Parry G; Rooney G; Sutcliffe P
Health Technol Assess; 2006 Sep; 10(33):iii, xi-xiv, 1-168. PubMed ID: 16959169
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of transdiagnostic cognitive-behavioral group therapy for anxiety disorders and headache in adolescents.
Sharma P; Mehta M; Sagar R
J Anxiety Disord; 2017 Mar; 46():78-84. PubMed ID: 27856068
[TBL] [Abstract][Full Text] [Related]
10. Internet-Delivered Cognitive Behavioural Therapy for Major Depression and Anxiety Disorders: A Health Technology Assessment.
Health Quality Ontario
Ont Health Technol Assess Ser; 2019; 19(6):1-199. PubMed ID: 30873251
[TBL] [Abstract][Full Text] [Related]
11. Manualised cognitive-behavioural therapy in treating depression in advanced cancer: the CanTalk RCT.
Serfaty M; King M; Nazareth I; Moorey S; Aspden T; Tookman A; Mannix K; Gola A; Davis S; Wood J; Jones L
Health Technol Assess; 2019 May; 23(19):1-106. PubMed ID: 31097078
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness and cost-utility evaluation of individual vs. group transdiagnostic psychological treatment for emotional disorders in primary care (PsicAP-Costs): a multicentre randomized controlled trial protocol.
Aguilera-Martín Á; Gálvez-Lara M; Cuadrado F; Moreno E; García-Torres F; Venceslá JF; Corpas J; Jurado-González FJ; Muñoz-Navarro R; González-Blanch C; Ruiz-Rodríguez P; Barrio-Martínez S; Prieto-Vila M; Carpallo-González M; Cano-Vindel A; Moriana JA
BMC Psychiatry; 2022 Feb; 22(1):99. PubMed ID: 35139809
[TBL] [Abstract][Full Text] [Related]
13. Intermittent Motivational Interviewing and Transdiagnostic CBT for Anxiety: A Randomized Controlled Trial.
Marker I; Corbett BE; Drummond SPA; Norton PJ
J Anxiety Disord; 2020 Oct; 75():102276. PubMed ID: 32768874
[TBL] [Abstract][Full Text] [Related]
14. Cost effectiveness of therapist delivered cognitive behavioural therapy and web-based self-management in irritable bowel syndrome: the ACTIB randomised trial.
McCrone P; Everitt H; Landau S; Little P; Bishop FL; O'Reilly G; Sibelli A; Holland R; Hughes S; Windgassen S; Goldsmith K; Coleman N; Logan R; Chalder T; Moss-Morris R
BMC Gastroenterol; 2021 Jul; 21(1):276. PubMed ID: 34229619
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of transdiagnostic group cognitive behavioural therapy versus group relaxation therapy for emotional disorders in primary care (PsicAP-Costs2): Protocol for a multicentre randomised controlled trial.
González-Blanch C; Barrio-Martínez S; Priede A; Martínez-Gómez S; Pérez-García-Abad S; Miras-Aguilar M; Ruiz-Gutiérrez J; Muñoz-Navarro R; Ruiz-Rodríguez P; Medrano LA; Prieto-Vila M; Carpallo-González M; Aguilera-Martín Á; Gálvez-Lara M; Cuadrado F; Moreno E; García-Torres F; Venceslá JF; Corpas J; Jurado-González FJ; Moriana JA; Cano-Vindel A
PLoS One; 2023; 18(3):e0283104. PubMed ID: 36928238
[TBL] [Abstract][Full Text] [Related]
16. Impact of group transdiagnostic cognitive-behavior therapy for anxiety disorders on comorbid diagnoses: Results from a pragmatic randomized clinical trial in primary care.
Norton PJ; Provencher MD; Kilby CJ; Roberge P
Depress Anxiety; 2021 Jun; ():. PubMed ID: 34142748
[TBL] [Abstract][Full Text] [Related]
17. An analysis of differential improvement by diagnosis in group transdiagnostic cognitive behaviour therapy for anxiety disorders.
Rostami M; Provencher MD; Roberge P; Norton PJ
J Ment Health; 2023 Jun; 32(3):619-624. PubMed ID: 36840371
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of transdiagnostic cognitive behaviour therapy for anxiety disorders: a systematic review and meta-analysis of published outcome studies.
Reinholt N; Krogh J
Cogn Behav Ther; 2014; 43(3):171-84. PubMed ID: 24646219
[TBL] [Abstract][Full Text] [Related]
19. Psychotherapy for Major Depressive Disorder and Generalized Anxiety Disorder: A Health Technology Assessment.
Health Quality Ontario
Ont Health Technol Assess Ser; 2017; 17(15):1-167. PubMed ID: 29213344
[TBL] [Abstract][Full Text] [Related]
20. START (STrAtegies for RelaTives) study: a pragmatic randomised controlled trial to determine the clinical effectiveness and cost-effectiveness of a manual-based coping strategy programme in promoting the mental health of carers of people with dementia.
Livingston G; Barber J; Rapaport P; Knapp M; Griffin M; Romeo R; King D; Livingston D; Lewis-Holmes E; Mummery C; Walker Z; Hoe J; Cooper C
Health Technol Assess; 2014 Oct; 18(61):1-242. PubMed ID: 25300037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
